新光光电(688011)1月5日晚公告，公司于2025年12月31日召开第三届董事会第七次会议，审议通过了 《关于部分募集资金投资项目延期的议案》，综合考虑当前募集资金投资项目（以下简称"募投项目"） 的实施进度等因素，公司决定对部分募投项目达到预定可使用状态的日期进行延期，本次延期未改变募 投项目的内容、投资用途、投资总额和实施主体。 "本项目契合国防和军队现代化建设战略部署，顺应军工电子信息行业发展趋势，是公司满足未来市场 订单需求、提升批产响应能力的必要举措；公司核心技术领先、客户合作稳定、项目经验丰富，具备充 分实施条件，延期调整符合审慎经营原则，未改变项目核心要素，具备继续实施的必要性与可行 性。"新光光电介绍。 对于睿光航天光电设备研发生产项目延期的原因，新光光电表示，2020至2022年，受不可抗力因素影 响，一方面，工程建设施工人员无法及时按原定计划满员满时施工。另一方面，在可调配资源有限的前 提下，公司集中资源维持主营业务的正常开展，一定程度上延缓了该项目进度。近两年公司在激光领域 围绕轻小型激光防御系统研发了多款产品，并经过了大量的外场测试，验证了系统对小型无人机的跟踪 能力及毁伤效果，目 ...

Core Viewpoint - 博瑞医药 has experienced a stock price increase and has announced a delay in several fundraising projects, which will not affect the company's normal operations or the intended use of funds [1][2][3]. Group 1: Stock Performance - As of December 26, 2025, 博瑞医药's stock closed at 50.21 yuan, up 3.31% from the previous week [1]. - The stock reached a high of 50.97 yuan and a low of 48.22 yuan during the week [1]. - The company's total market capitalization is 20.757 billion yuan, ranking 22nd in the chemical pharmaceutical sector and 947th among all A-shares [1]. Group 2: Company Announcements - 国联民生证券 conducted a site inspection for 博瑞医药's 2025 annual continuous supervision, finding no violations in governance, information disclosure, or major investments [2][6]. - 博瑞医药's board approved a resolution to postpone the expected operational status date for several fundraising projects to March 2027 due to pending product approvals and the addition of an automated warehouse [2][3]. - The delay affects projects including the inhalation and chemical drug formulation production base and the biopharmaceutical R&D center [2][3]. Group 3: Internal Governance - 博瑞医药 has established an internal audit system to oversee internal controls, financial information, and operational activities [4]. - The company has implemented a management system for forward foreign exchange transactions to mitigate exchange rate risks [4]. - A fundraising management method has been developed to ensure that raised funds are used specifically for intended projects and are subject to strict oversight [5][6]. Group 4: Management Regulations - 博瑞医药 has set up a management system for shares held by directors and senior management, regulating trading periods and disclosure requirements [7].

中科星图公告称，公司于2025年12月30日召开董事会，审议通过《关于GEOVISOnline在线数字地球建 设项目延期的议案》。2022年公司募资15.33亿元，原计划该项目于2025年12月达到预定可使用状态， 现延期至2026年6月。截至2025年底，募投项目募集资金余额为2.13亿元。延期原因是受超高层建筑施 工复杂度影响，研发中心竣工验收未完成。该事项无需提交股东会审议，保荐机构无异议。 ...

Core Viewpoint - The company Beiqing Song is under scrutiny due to its actual controller being investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, leading to a significant decline in its market value and financial performance since its IPO in 2021 [2][16]. Financial Performance - Beiqing Song's market capitalization has decreased to 1.88 billion yuan, down 46.05% from its peak within the year, and over 80% since its IPO [2]. - The company's recent financial reports indicate a revenue decline of 28.51% year-on-year, with a net loss of 29.51 million yuan, marking a 126.43% increase in losses compared to the previous year [17]. - Cumulatively, for the first three quarters, the revenue was 55.2 million yuan, down 34.07%, with a net loss of 65.63 million yuan, representing a 600.98% increase in losses [18]. Corporate Governance Issues - The actual controller, Ma Xuejun, has been involved in fund occupation totaling over 10.9 million yuan through various means, including employee loans and early payments to suppliers [4][7]. - Ma Xuejun also reduced his stake in the company by transferring approximately 2.97% of the total shares for 64.71 million yuan, indicating potential liquidity issues [8][10]. Project Delays and Financial Management - Beiqing Song's last fundraising project was concluded in December, with a remaining balance of 19.21 million yuan from an initial commitment of 88.01 million yuan, reflecting significant project delays and budget discrepancies [12][15]. - The company has faced multiple project delays, with some projects taking over two years longer than planned, and actual investments falling short of initial commitments [15]. Market Position and Strategy - The company has experienced a decline in both domestic and international sales, with revenue from various product lines dropping by over 20%, and shoulder products seeing a staggering 62% decline [19]. - Beiqing Song's strategy to expand its offline retail presence has faltered, with the number of direct stores decreasing from 186 to 125, attributed to declining single-store revenues [24]. - Despite a temporary surge in online sales, particularly through platforms like Douyin, the company has seen a subsequent decline in online direct sales revenue, primarily due to reduced promotional investments [26][27].

12月29日，雷尔伟（301016）披露部分募投项目延期的公告。 经公司第三届董事会第十一次会议审议通过，雷尔伟将部分募投项目"轨道交通装备智能生产线建设项 目"、"研发中心建设项目"可使用状态时间调整至2026年12月31日。 这不是雷尔伟首次披露募投项目延期。 2023年3月31日，雷尔伟首次披露募投项目延期公告，公司将"轨道交通装备智能生产线建设项目"的建 设期截止时间由 2023 年 6 月延长至 2024 年 6 月，将"研发中心建设项目"的建设期截止时间由 2022 年 12 月延 长至 2024 年 6 月。 | 1 | 2025-12-29 | 雷尔伟:关于部分纂投项目延期的公告 | | --- | --- | --- | | 3 | 2025-12-29 | 雷尔伟:国联民生证券承销保存限公司关于南京雷尔伟新技术股份有限公司纂投项目延期的专项核直意… | | | 2024-04-25 | 雷尔伟:关于幕投项目延期的公告 | | 4 | 2024-04-25 | 雷尔伟:民生证券股份有限公司关于南京雷尔伟新技术股份有限公司纂投项目延期的核查意见 | | 5 | 2023-03-31 | 雷尔伟 ...

Core Viewpoint - The company has announced a delay in the "Chengdu Battery Connection System Production Project," pushing the expected completion date from Q4 2025 to Q4 2026 due to external environmental impacts and lengthy approval processes [2][3] Group 1: Project Delay - The delay is attributed to external factors affecting the project and the prolonged approval process for foundational construction, leading to a slowdown in construction progress [2] - The decision to postpone was made to ensure project quality and smooth progress without changing the project implementation entity, method, purpose, or total investment [2] Group 2: Financial Overview - The company completed its initial public offering in January 2024, raising a net amount of 1.073 billion yuan, which will be allocated to various projects including the Chengdu Battery Connection System Production Project [2] - As of November 30, 2025, the total expected investment for the Chengdu project is 385 million yuan, with 201 million yuan already invested from the raised funds [2] Group 3: Impact of Delay - The company stated that the adjustment only affects the investment schedule and will not have a substantial impact on project implementation or current operations [3] - The delay is viewed as beneficial for ensuring high-quality project execution, aligning with the company's long-term development plans [3]

南财智讯12月30日电，湘潭电化公告，公司拟将募投项目"年产3万吨尖晶石型锰酸锂电池材料项目"整 体建设完工期由2025年12月31日延长至2026年12月31日。该项目计划投入募集资金4.78亿元，资金来源 于向不特定对象发行可转换公司债券，用于新增锰酸锂产能。延期原因为公司结合技术研发和客户开发 进度，审慎控制投资节奏，合理配置资源，以保障项目建设质量与预期效果。项目一期年产2万吨生产 线已建成投产，公司锰酸锂年产能已达4万吨。本次延期不涉及项目实施主体、用途、投资规模的变 更，不影响募集资金投向，不存在损害股东利益的情形，不会对公司当前生产经营造成不利影响，符合 公司长期发展规划。 ...

【财经网讯】12月29日，宇信科技（300674）发布第四届董事会第十一次会议决议公告，宣布审议通过 《关于募投项目建设期延期的议案》。公司表示，此次延期是基于经营情况、发展战略及市场环境变化 作出的审慎决策，旨在提高募集资金使用效率。 公告显示，本次董事会会议于2025年12月29日以通讯方式召开，应到董事8人，实到董事8人，会议由董 事长洪卫东主持。会议召集与召开程序符合《公司法》及《公司章程》规定，表决结果为8票同意、0票 反对、0票弃权，议案获得全票通过。 本次会议还审议通过了相关备查文件，包括董事会决议及审计与风险控制委员会决议等。 点击查看公告原文>> 声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 责任编辑：小浪快报 董事会指出，募 ...

每经AI快讯，宇信科技（SZ 300674，收盘价：23.13元）12月29日晚间发布公告称，公司第四届第十一 次董事会会议于2025年12月29日以通讯会议的方式召开。会议审议了《关于募投项目建设期延期的议 案》。 每经头条（nbdtoutiao）——绕开光刻机"卡脖子"，中国新型芯片问世！专访北大孙仲：支撑AI训练和 具身智能，可在28纳米及以上成熟工艺量产 （记者 曾健辉） 2025年1至6月份，宇信科技的营业收入构成为：银行占比84.07%，其他占比9.14%，非银金融机构占比 6.79%。 截至发稿，宇信科技市值为163亿元。 ...

出品：新浪财经上市公司研究院 作者：郝显 近日，湘佳股份发布公告，宣布对部分募投项目进行延期。公司称"养殖行业处于低迷周期，项目整体 进度放缓"，事实上，在市场行情低迷影响下，前期已完工项目仍未能实现预定收益。 目前的湘佳股份经过持续扩张之后，固定资产和有息负债均处在高位。而公司毛利率持续下滑，费用率 下滑幅度有限，利润空间不断压缩。 湘佳股份募投项目延期 股东不断减持 12月26日，湘佳股份发布公告，拟对部分募投项目进行延期。2022年4月，湘佳股份发行可转债募资6.4 亿元（募资净额6.3亿元），主要投向两大项目——1350万羽优质鸡标准化养殖基地项目及1万头种猪养 殖基地项目。 截至2025年12月20日，公司募集资金已累计投入4.48亿元，募集资金账户余额为1.91亿元。本次拟对"夹 山镇栗山村张家山鸡场"、"夹山镇浮坪村鸡场（注）"、"太平镇滚子坪畜禽种苗基地"三个项目进行延 期，将达到预定可使用状态日期从2025年12月31日延期至2026年12月31日。 公司给出的原因是，由于宏观环境因素影响时间较长，在募投项目实施过程中，场地建设、设备购置等 各方面均受到了一定制约，且养殖行业处于低迷周期，项 ...